262 related articles for article (PubMed ID: 16246964)
1. Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans.
Borlaug BA; Melenovsky V; Marhin T; Fitzgerald P; Kass DA
Circulation; 2005 Oct; 112(17):2642-9. PubMed ID: 16246964
[TBL] [Abstract][Full Text] [Related]
2. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
3. The effects of sildenafil on ocular blood flow.
Koksal M; Ozdemir H; Kargi S; Yesilli C; Tomaç S; Mahmutyazicioglu K; Mungan A
Acta Ophthalmol Scand; 2005 Jun; 83(3):355-9. PubMed ID: 15948790
[TBL] [Abstract][Full Text] [Related]
4. Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure.
Senzaki H; Smith CJ; Juang GJ; Isoda T; Mayer SP; Ohler A; Paolocci N; Tomaselli GF; Hare JM; Kass DA
FASEB J; 2001 Aug; 15(10):1718-26. PubMed ID: 11481219
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.
Bharani A; Mathew V; Sahu A; Lunia B
Indian Heart J; 2003; 55(1):55-9. PubMed ID: 12760589
[TBL] [Abstract][Full Text] [Related]
6. The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects.
Kruuse C; Thomsen LL; Jacobsen TB; Olesen J
J Cereb Blood Flow Metab; 2002 Sep; 22(9):1124-31. PubMed ID: 12218418
[TBL] [Abstract][Full Text] [Related]
7. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
[TBL] [Abstract][Full Text] [Related]
10. The effects of tamsulosin and sildenafil in separate and combined regimens on detailed hemodynamics in patients with benign prostatic enlargement.
Nieminen T; Tammela TL; Kööbi T; Kähönen M
J Urol; 2006 Dec; 176(6 Pt 1):2551-6. PubMed ID: 17085157
[TBL] [Abstract][Full Text] [Related]
11. PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.
Guazzi M; Vicenzi M; Arena R; Guazzi MD
Circ Heart Fail; 2011 Jan; 4(1):8-17. PubMed ID: 21036891
[TBL] [Abstract][Full Text] [Related]
12. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
[TBL] [Abstract][Full Text] [Related]
13. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
Takimoto E; Champion HC; Belardi D; Moslehi J; Mongillo M; Mergia E; Montrose DC; Isoda T; Aufiero K; Zaccolo M; Dostmann WR; Smith CJ; Kass DA
Circ Res; 2005 Jan; 96(1):100-9. PubMed ID: 15576651
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of sildenafil in hypertensive men with erectile dysfunction and different alleles of the type 5 cGMP-specific phosphodiesterase (PDE5).
Salvi F; Sarzani R; Giorgi R; Donatelli G; Pietrucci F; Micheli A; Baldoni M; Minardi D; Dessì-Fulgheri P; Polito M; Muzzonigro G; Rappelli A
Int J Impot Res; 2004 Oct; 16(5):412-7. PubMed ID: 15175637
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil (Viagra) evokes retinal arteriolar dilation: dual pathways via NOS activation and phosphodiesterase inhibition.
Yuan Z; Hein TW; Rosa RH; Kuo L
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):720-5. PubMed ID: 18235020
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients.
Attinà TM; Malatino LS; Maxwell SR; Padfield PL; Webb DJ
J Hypertens; 2008 Mar; 26(3):501-7. PubMed ID: 18300861
[TBL] [Abstract][Full Text] [Related]
17. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
Takimoto E; Champion HC; Li M; Belardi D; Ren S; Rodriguez ER; Bedja D; Gabrielson KL; Wang Y; Kass DA
Nat Med; 2005 Feb; 11(2):214-22. PubMed ID: 15665834
[TBL] [Abstract][Full Text] [Related]
18. Effects of sildenafil on retinal blood flow and flicker-induced retinal vasodilatation in healthy subjects.
Polak K; Wimpissinger B; Berisha F; Georgopoulos M; Schmetterer L
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4872-6. PubMed ID: 14578411
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 5A inhibition induces Na+/H+ exchanger blockade and protection against myocardial infarction.
Pérez NG; Piaggio MR; Ennis IL; Garciarena CD; Morales C; Escudero EM; Cingolani OH; Chiappe de Cingolani G; Yang XP; Cingolani HE
Hypertension; 2007 May; 49(5):1095-103. PubMed ID: 17339532
[TBL] [Abstract][Full Text] [Related]
20. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
